White Papers

Our white papers are summaries of studies that provide important clinical evidence demonstrating the exceptional efficacy of balloon embolization.

 

NEW! The Method of B-TACE White Paper

Our newest white paper discusses the method behind B-TACE and the benefits to both patients and physicians.

Efficacy White Paper

Our Efficacy white paper provides an in-depth description of the superior efficacy of B-TACE as compared to TACE with a standard microcatheter.

Tracking White Paper

Download our latest white paper and learn about the super selective tracking capabilities of Sniper in tumor and prostate artery embolization!

  1. Rose S, Halstead G, Narsinh K. Pressure-Directed Embolization of Hepatic Arteries in a Porcine Model Using a Temporary Occlusion Balloon Microcatheter: Proof of Concept. Cardiovasc Intervent Radiol (2017) 40: 1769.
  2. Isaacson A, Hartman T, Bagla S, Burke C. Initial Experience with Balloon-Occlusion Prostatic Artery Embolization. J Vasc Interv Radiol (2018) 29: 85-89.
  3. Maruyama M, Yoshizako T, Nakamura T, et al. Initial Experience with Balloon-Occluded Trans-catheter Arterial Chemoembolization (B-TACE) for Hepatocellular Carcinoma. Cardiovasc Intervent Radiol (2016) 39: 359-366.
  4. Irie T, Kuramochi M, Takahashi N. Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodules during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure. Cariovasc Intervent Radiol (2013) 36: 706-713.
  5. Ogawa M, Takayasu K, Hirayama M, et al. Efficacy of a microballoon catheter in transarterial chemoembolization using miriplatin, a lipophilic anticancer drug: short-term results. Hepatology Research (2016) 46: E60-69.
  6. Arai H, Abe T, Takayama H, et al. Safety and efficacy of balloon-occluded transcatheter arterial chemoembolization using miriplatin for hepatocellular carcinoma. Hepatology Research (2015) 45: 663-666.
  7. Irie T, Kuramochi M, Kamoshida T, Takahashi N. Selective balloon-occluded transarterial chemoembolization for patients with one or two hepatocellular carcinoma nodules: retrospective comparison with conventional super-selective TACE. Hepatology Research (2016) 46: 209-214.
  8. Stephan Ogenstad, Statogen Consulting LLC. Meta-analysis of clinical studies performed by: Ogawa (2016) ref. 5, Arai (2015) ref. 6, and Irie (2016) ref. 7. Analysis on file at Embolx, Inc. (2017).